These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38341039)

  • 21. Real-world evidence on the use of a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) in people with suboptimally controlled type 2 diabetes in Romania: a prospective cohort study (STAR.Ro).
    Bala C; Cerghizan A; Mihai BM; Moise M; Guja C
    BMJ Open; 2022 May; 12(5):e060852. PubMed ID: 35623748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2i) during the month of Ramadan in patients with type 2 diabetes mellitus in Pakistani population-an observational study from a tertiary care center in Karachi.
    Sheikh A; Das B; Sattar S; Islam N
    Endocrine; 2023 Apr; 80(1):64-70. PubMed ID: 36580199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial.
    Hassanein MM; Sahay R; Hafidh K; Djaballah K; Li H; Azar S; Shehadeh N; Hanif W
    Diabetes Res Clin Pract; 2019 Apr; 150():331-341. PubMed ID: 30772385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indonesia DIA-RAMADAN Study: A Real-life, Prospective and Observational of Gliclazide MR in Type-2 Diabetes Patients During Ramadan Fasting.
    Soelistijo SA; Aman AM; Zufry H; Pranoto A; Rudijanto A; Hassanien M
    Acta Med Indones; 2022 Jan; 54(1):3-9. PubMed ID: 35398820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Ramadan Diurnal Intermittent Fasting on Hypoglycemic Events in Patients With Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials and Observational Studies.
    Abdelrahim D; Faris ME; Hassanein M; Shakir AZ; Yusuf AM; Almeneessier AS; BaHammam AS
    Front Endocrinol (Lausanne); 2021; 12():624423. PubMed ID: 33763029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN.
    Hassanein M; Al Sifri S; Shaikh S; Abbas Raza S; Akram J; Pranoto A; Rudijanto A; Shaltout I; Fariduddin M; Mohd Izani Wan Mohamed W; Al Awadi F; Alessa T;
    Diabetes Res Clin Pract; 2020 May; 163():108154. PubMed ID: 32330510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study).
    Elhadd T; Bashir M; Baager KA; Ali HA; Almohannadi DHS; Dabbous Z; Malik RA; Abou-Samra AB;
    Diabetes Res Clin Pract; 2021 Feb; 172():108589. PubMed ID: 33316309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of vildagliptin relative to sulfonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the Middle East: the VIRTUE study.
    Hassoun AA; Al-Arouj M; Ibrahim M
    Curr Med Res Opin; 2017 Jan; 33(1):161-167. PubMed ID: 27684469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial.
    Watada H; Takami A; Spranger R; Amano A; Hashimoto Y; Niemoeller E
    Diabetes Care; 2020 Jun; 43(6):1249-1257. PubMed ID: 32295808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus.
    Alawadi F; Alsaeed M; Bachet F; Bashier A; Abdulla K; Abuelkheir S; Rashid F; Abdulaziz Bin Hussain A; Abdelgadir E; Alsayyah F; Elsayed M; Hassanein M
    Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitude, complications, ability of fasting and glycemic control in fasting Ramadan by children and adolescents with type 1 diabetes mellitus.
    Deeb A; Al Qahtani N; Akle M; Singh H; Assadi R; Attia S; Al Suwaidi H; Hussain T; Naglekerke N
    Diabetes Res Clin Pract; 2017 Apr; 126():10-15. PubMed ID: 28189949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study using flash continuous glucose monitoring in patients with type-2 diabetes on multiple anti-diabetic agents during Ramadan.
    Bashir M; Elhadd T; Ali H; Baagar K; Abdel Hakam IA; Al-Mohanadi DHS; Naem E; Al Abdulla A; Mohammed K; Abou-Samra AB
    Diabetes Metab Syndr; 2018 Nov; 12(6):965-968. PubMed ID: 29895446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan.
    Salti I;
    Diabet Med; 2009 Dec; 26(12):1255-61. PubMed ID: 20002478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment Options for Patients with Type 2 Diabetes Mellitus during the Fasting Month of Ramadan.
    Loh HH; Kamaruddin NA
    Ann Acad Med Singap; 2020 Jul; 49(7):468-476. PubMed ID: 33000110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care.
    Alawadi F; Rashid F; Bashier A; Abdelgadir E; Al Saeed M; Abuelkheir S; Khalifa A; Al Sayyah F; Bachet F; Elsayed M; Abdallah K; Hassanein M
    Diabetes Res Clin Pract; 2019 May; 151():305-312. PubMed ID: 30880094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of optimum diabetes care on the safety of fasting in Ramadan in adult patients with type 2 diabetes mellitus on insulin therapy.
    Bashier AMK; Hussain AKB; Alawadi F; Alsayyah F; Alsaeed M; Rashid F; Abdelgadir E; Bachet F; Abuelkheir S; Elsayed M; Hassanein M
    Diabetes Res Clin Pract; 2019 Apr; 150():301-307. PubMed ID: 30768940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of lixisenatide plus basal insulin treatment regimen in Indian people with type 2 diabetes mellitus during Ramadan fast: A post hoc analysis of the LixiRam randomized trial.
    Sahay R; Hafidh K; Djaballah K; Coudert M; Azar S; Shehadeh N; Hanif W; Hassanein M
    Diabetes Res Clin Pract; 2020 May; 163():108148. PubMed ID: 32302665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive impact of pre-Ramadan education on glycemic control and reducing risk of hypoglycemia in type 2 diabetic elderly patients during COVID 19 pandemic.
    El Toony LF; Elghazally SA; Hamad DA
    Prim Care Diabetes; 2022 Aug; 16(4):581-587. PubMed ID: 35491316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM).
    Al Awadi FF; Echtay A; Al Arouj M; Sabir Ali S; Shehadeh N; Al Shaikh A; Djaballah K; Dessapt-Baradez C; Omar Abu-Hijleh M; Bennakhi A; El Hassan Gharbi M; El Sayed El Hadidy K; Abdul Kareem Khazaal F; Hassanein MM
    Adv Ther; 2020 Apr; 37(4):1550-1563. PubMed ID: 32144714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.